Skip to content
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Resources
2024 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
Resources
2024 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
Advocacy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
GRx+Biosims 2025
Access! 2026
Press Releases
JOIN
Advocacy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
GRx+Biosims 2025
Access! 2026
Press Releases
JOIN
SideMenu
Association for Accessible Medicines
About the Association
Our Members
Our Members
2025 AAM Regular Members
Accord Healthcare, Inc.
Ajanta Pharma USA Inc.
American Regent
Amneal Pharmaceuticals
Amphastar Pharmaceuticals, Inc.
Apotex Corp
.
Aurobindo Pharma USA, Inc.
B. Braun Medical Inc.
Biocon Biologics Limited
Cipla USA
Dr. Reddy’s Laboratories, Inc.
Fresenius Kabi USA
Glenmark Pharmaceuticals, Inc. USA
Hikma Pharmaceuticals USA
Jubilant Cadista Pharmaceuticals, Inc.
Lupin Inc.
Meitheal Pharmaceuticals
MSN Pharmaceuticals Inc.
Padagis LLC
PAI Pharma
Sandoz Inc.
Somerset Therapeutics LLC
Strides Pharma Inc.
Sun Pharmaceutical Industries, Inc.
Teva Pharmaceuticals USA, Inc.
Torrent Pharma Inc.
Zydus Pharmaceuticals USA, Inc.
2025 AAM Associate Members
ACIC Pharmaceuticals
Catholic Medical Mission Board, Inc. (CMMB)
ChemWerth Inc.
Direct Relief
Dispensary of Hope
Gedeon Richter USA
Husch Blackwell
Lachman Consultant Services, Inc.
MAP International
Operation Smile
Learn how your generic and biosimilar industry is
committed to your health
.
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Video
August 22, 2025
AAM
Mark Your Calendar for Access! 2026
Recent News
Press Releases
July 21, 2025
AAM
AAM Congratulates Dr. Tidmarsh on Appointment as Director of CDER
Press Releases
July 15, 2025
AAM
Amphastar to Quadruple Domestic Manufacturing
AAM Tweets
Resources
2024 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
GRx+Biosims 2025
Access! 2026
Press Releases
JOIN
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Resources
2024 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
Advocacy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
GRx+Biosims 2025
Access! 2026
Press Releases
JOIN
